Head-To-Head Contrast: Pro-Dex (NASDAQ:PDEX) & Olympus (OTCMKTS:OCPNY)

Olympus (OTCMKTS:OCPNY – Get Free Report) and Pro-Dex (NASDAQ:PDEX – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Risk and Volatility

Olympus has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Olympus and Pro-Dex, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Olympus 0 0 1 0 3.00
Pro-Dex 0 1 2 0 2.67

Pro-Dex has a consensus target price of $80.00, indicating a potential upside of 26.98%. Given Pro-Dex’s higher possible upside, analysts plainly believe Pro-Dex is more favorable than Olympus.

Earnings & Valuation

This table compares Olympus and Pro-Dex”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Olympus $7.74 billion 2.99 $1.03 billion $0.82 21.95
Pro-Dex $77.55 million 2.60 $13.66 million $3.65 17.26

Olympus has higher revenue and earnings than Pro-Dex. Pro-Dex is trading at a lower price-to-earnings ratio than Olympus, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Olympus and Pro-Dex’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Olympus 13.80% 24.30% 9.30%
Pro-Dex 15.12% 26.18% 16.69%

Insider & Institutional Ownership

0.0% of Olympus shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 48.0% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Pro-Dex beats Olympus on 8 of the 14 factors compared between the two stocks.

About Olympus

(Get Free Report)

Olympus Corporation is a Japan-based medical technology company focused on developing and supplying equipment and services for medical procedures. Its products include gastrointestinal endoscopes and related systems, surgical endoscopes, and endotherapy devices used in diagnosis and treatment. The company’s roots date to 1919, when it was established in Japan as Takachiho Seisakusho to produce microscopes. Over time, Olympus became known for optical products, but it has since exited its camera and scientific solutions businesses to concentrate on medical technology.

About Pro-Dex

(Get Free Report)

Pro-Dex, Inc. designs, develops and manufactures powered surgical instruments and related accessories, with a focus on devices used in orthopedic procedures. Its products include surgical handpieces and drivers, along with the components and systems that support their operation. The company also provides engineering, product development and manufacturing services to medical device companies. Its work can span the product lifecycle, from design and prototyping to production and servicing. Founded in 1978, Pro-Dex is headquartered in Irvine, California, and serves customers in the United States and international markets.

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.